<DOC>
	<DOCNO>NCT02819310</DOCNO>
	<brief_summary>The objective study evaluate safety chronic use BLI400 laxative constipate adult .</brief_summary>
	<brief_title>An Open Label Study Chronic Use BLI400 Laxative Constipated Adults</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Laxatives</mesh_term>
	<mesh_term>Cathartics</mesh_term>
	<criteria>1 . Male female subject least 18 year age 2 . Constipated , define follow adapt ROME II definition : Fewer 3 spontaneous defecation per week least one follow symptom least 12 week ( need consecutive ) precede 12 month : Straining &gt; 25 % defecation Lumpy hard stool &gt; 25 % defecation Sensation incomplete evacuation &gt; 25 % defecation 3 . If female , childbearing potential , use acceptable form birth control ( hormonal birth control , IUD , doublebarrier method , depot contraceptive , sterilize , abstinent , vasectomize spouse ) 4 . Negative urine pregnancy test screening , applicable 5 . In Investigator 's judgment , subject mentally competent provide inform consent participate study 1 . Report loose ( mushy ) water stools absence laxative use 25 % BMs 12 week Visit 1 2 . Meet Rome II criterion Irritable Bowel Syndrome 3 . Subjects know suspected ileus , gastrointestinal obstruction , gastric retention , bowel perforation , toxic colitis , toxic megacolon 4 . Subjects major surgery 30 day Visit 1 ; appendectomy cholecystectomy 60 day Visit 1 ; abdominal , pelvic , retroperitoneal surgery 6 month Visit 1 ; bariatric surgery surgery remove segment GI tract time Visit 1 5 . Subjects hypothyroidism treat dose thyroid hormone stable least 6 week time Visit 1 6 . Subjects take laxative , enemas prokinetic agent refuse discontinue treatment Visit 1 completion Visit 6 7 . Subjects pregnant lactating , intend become pregnant study 8 . Subjects childbearing potential refuse pregnancy test 9 . Subjects allergic BLI400 component 10 . Subjects take narcotic analgesic medication know cause constipation . 11 . Subjects clinically significant cardiac abnormality identify Visit 1 ECG 12 . Subjects clinically significant laboratory abnormality , deem potential safety issue Investigator , may discontinue Investigator 's discretion . 13 . Subjects , opinion Investigator , include study reason , include inability follow study procedure 14 . Subjects participate investigational clinical , surgical , drug , device study within past 30 day 15 . Subjects active history drug alcohol abuse 16 . Subjects hospitalize psychiatric condition make suicide attempt 2 year Visit 1 17 . Subjects withdraw consent time prior completion Visit 1 procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>